Sinopharm
1099.HK
#2023
Rank
A$12.45 B
Marketcap
$3.99
Share price
-1.25%
Change (1 day)
-5.92%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Market capitalization of Sinopharm (1099.HK)

Market cap: A$12.45 Billion

As of February 2025 Sinopharm has a market cap of A$12.45 Billion. This makes Sinopharm the world's 2023th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Sinopharm from 2009 to 2025

End of year Market Cap

Year Marketcap Change
2025A$12.45 B-11.82%
2024A$14.12 B17.74%
2023A$11.99 B2.74%
2022A$11.67 B24.7%
2021A$9.36 B-0.21%
2020A$9.38 B-39.49%
2019A$15.50 B-12.51%
2018A$17.72 B15.64%
2017A$15.32 B-3.1%
2016A$15.81 B3.77%
2015A$15.24 B27.37%
2014A$11.96 B44.83%
2013A$8.26 B14.22%
2012A$7.23 B28.58%
2011A$5.62 B-27.54%
2010A$7.76 B-13.33%
2009A$8.95 B

End of Day market cap according to different sources

On Feb 20th, 2025 the market cap of Sinopharm was reported to be:

A$12.60 Billion
by Yahoo Finance info icon info icon
A$12.60 Billion
by CompaniesMarketCap info icon info icon